The Body: Unveiling UltraShape

The growing patient demand for noninvasive body shaping solutions that offer minimal discomfort and no downtime is good news for Syneron-Candela, whose UltraShape earned a nod from the FDA in April 2014 for abdominal circumference reduction via fat cell disruption.